Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Current Assets (2023 - 2025)

Metagenomi (MGX) has disclosed Current Assets for 3 consecutive years, with $165.5 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 35.83% to $165.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $165.5 million through Dec 2025, down 35.83% year-over-year, with the annual reading at $165.5 million for FY2025, 35.83% down from the prior year.
  • Current Assets for Q4 2025 was $165.5 million at Metagenomi, down from $189.8 million in the prior quarter.
  • The five-year high for Current Assets was $335.6 million in Q1 2024, with the low at $165.5 million in Q4 2025.
  • Average Current Assets over 3 years is $251.3 million, with a median of $258.0 million recorded in 2024.
  • The sharpest move saw Current Assets dropped 7.3% in 2024, then plummeted 35.83% in 2025.
  • Over 3 years, Current Assets stood at $278.3 million in 2023, then decreased by 7.3% to $258.0 million in 2024, then tumbled by 35.83% to $165.5 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $165.5 million, $189.8 million, and $211.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.